 |
Dextrans
Research News and Information
Definition of 'Dextrans'A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Common names: Dextrans; Rheopolyglucin; Dextran; Dextran 40; Dextran 40000; Dextran 70; Dextran 75; Dextran 80; Dextran B-1355-S; Dextran B 1355 S; Dextran B1355; Dextran B-1355; Dextran B 1355; Dextran B512; Dextran M 70; Dextran T 70; Dextran T-40; Dextran T 40; Dextran T-500; Dextran T 500; Hemodex; Hyskon |
Saturday, November 21, 2009
13 Nov 2009 
Delimotecan (MEN 4901/T-0128) is a new cytotoxic prodrug constituted by a camptothecin analog (T-2513) bound to carboxymethyl dextran through a triglycine linker. A significant antitumor activity of delimotecan against human metastatic melanoma ... Read more...
18 Oct 2009 The topography and morphology of retinal ganglion cells (RGCs) in the eastern newt were studied. Cells were retrogradely labeled with tetramethylrhodamine-conjugated dextran amines or horseradish peroxidase and examined in retinal wholemounts. Their ... Read more...
Tissue responses to novel tissue engineering biodegradable cryogel scaffolds: an animal model.
29 Sep 2009 Biodegradable macroporous cryogels with highly open and interconnected pore structures were produced from dextran modified with oligo L-lactide bearing hydroxyethylmethacrylate (HEMA) end groups in moderately frozen solutions. Tissue responses to ... Read more...
Latest indexed articles for 'Dextrans'
These are the very latest articles for this heading:
- Antitumor activity of delimotecan against human metastatic melanoma: pharmacokinetics and molecular determinants. 13 Nov 2009
- Retinal ganglion cells in the eastern newt Notophthalmus viridescens: topography, morphology, and diversity. 18 Oct 2009
- Tissue responses to novel tissue engineering biodegradable cryogel scaffolds: an animal model. 29 Sep 2009
- Nonadditive effects of mixed crowding on protein stability. 29 Sep 2009
- Editorial comment.
29 Sep 2009 - Preparation, characterization, in-vitro drug release and cellular uptake of poly(caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug. 13 Sep 2009
- Matrix therapy in regenerative medicine, a new approach to chronic wound healing. 30 Aug 2009
- Stable oil-in-water emulsions prepared from soy protein-dextran conjugates. 30 Aug 2009
- The effect of bulking agents on the chemical stability of acid-sensitive compounds in freeze-dried formulations: sucrose inversion study. 30 Aug 2009
- Temperature scanning FTIR analysis of secondary structures of proteins embedded in amorphous sugar matrix. 30 Aug 2009
- The W cell pathway to cat primary visual cortex. 30 Aug 2009
- Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model. 30 Aug 2009
- Arcobacter butzleri induces barrier dysfunction in intestinal HT-29/B6 cells. 30 Aug 2009
- Patterning: Cells nourished by nanodrops. 30 Aug 2009
- Preparation and biodistribution of radiolabeled fullerene C60 nanocrystals. 26 Aug 2009
- Negative guidance factor-induced macropinocytosis in the growth cone plays a critical role in repulsive axon turning. 24 Aug 2009
- Dielectric properties of thermo-reversible hydrogels: the case of a dextran copolymer grafted with poly(N-isopropylacrylamide). 18 Aug 2009
- Effect of dynamic loading on the transport of solutes into agarose hydrogels. 17 Aug 2009
- Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection. 16 Aug 2009
- Editorial comment. 16 Aug 2009
See a longer list of these articles.
Technical information about 'Dextrans'
Definition: A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.
Registry Number: 9004-54-0
Descriptor UI: D003911
Alternative terms: Dextrans; Rheopolyglucin; Dextran; Dextran 40; Dextran 40000; Dextran 70; Dextran 75; Dextran 80; Dextran B-1355-S; Dextran B 1355 S; Dextran B1355; Dextran B-1355; Dextran B 1355; Dextran B512; Dextran M 70; Dextran T 70; Dextran T-40; Dextran T 40; Dextran T-500; Dextran T 500; Hemodex; Hyskon; Infukoll; Macrodex; Polyglucin; Promit; Rheodextran; Rheoisodex; Rheomacrodex; Rondex; Saviosol;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; ultrastructure;
Pharmacological Action: Anticoagulants; Plasma Substitutes;
Tree Number: D05.750.078.562.272; D09.698.365.272;
Online Note: use DEXTRANS to search DEXTRAN 1966-78
History Note: 79; was DEXTRAN 1963-78